ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
ARLZ
Delisted
ARLZ was delisted on the 20th of August, 2018.
48 hedge funds and large institutions have $1.8M invested in Aralez Pharmaceuticals Inc. in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
89% less capital invested
Capital invested by funds: $16M → $1.8M (-$14.2M)
Holders
48
Holding in Top 10
–
Calls
$66K
Puts
$67K
Top Buyers
| 1 | +$97.1K | |
| 2 | +$35K | |
| 3 | +$32.6K | |
| 4 |
Millennium Management
New York
|
+$19K |
| 5 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$18.2K |
Top Sellers
| 1 | -$1.38M | |
| 2 | -$468K | |
| 3 | -$434K | |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$425K |
| 5 |
BAS
Brown Advisory Securities
Baltimore,
Maryland
|
-$408K |